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Ashrafian H et al. published in the prestigious journal CANCER, 
in May 2011, an extensive review on the beneficial effects of 
bariatric surgery over the decrease of cancer cases in obese 
people who underwent this surgery.1
Bariatric surgery causes several anatomical and physio-
logical alterations, such as bile flow, decrease of stomach size, 
change of nutrients flow in the intestine, and modulation of 
intestinal hormones.
The clinical treatment for obesity has been discouraging 
since it is not able to maintain weight loss in the long term. The 
use of metabolic surgery accounted for 350 thousand patients 
operated worldwide up to that date. In these patients weight 
decreased sustainably and there was a beneficial effect over 
the so-called metabolic syndrome. One unexpected result 
in these operated patients was the declining rates of cancer 
versus non-operated obese patients.
The surgery leads to a decrease in caloric intake, which 
on its own decreases carcinogenesis, as demonstrated by 
several studies. Other factors also influencing the decrease in 
cancer rate are increased physical activity allowed by weight 
decrease, and changes in insulin levels, hormonal factors and 
inflammatory mediators.
Obesity is associated with chronic inflammation caused by 
the increase of interleukins and tumor necrosis factor. These 
inflammatory mediators eventually become carcinogenic. 
With weight loss, there is a change in these factors ultimately 
leading to the decrease in inflammation and carcinogenesis. 
Six months after the metabolic surgery, interleukins decrease, 
leading to a higher activity of natural killer (NK) cells, and thus 
resulting in an increase of antitumor immune response.
Another important factor in reducing cancer rates is the 
decrease of hepatic steatosis in patients who underwent 
metabolic surgery. The decrease of steatosis leads to the 
decrease of hepatic inflammation and consequent decrease of 
cirrhosis and liver cancer. The decrease in leptin production by 
fat cells in operated patients also leads to a decrease in tumor 
rate, since leptin is a stimulant of carcinogenesis. Changes in 
concentrations of sex hormones also leads to the reduction 
of breast cancer, for instance, in women who underwent 
metabolic surgery.
Intestinal hormones such as ghrelin (which reduces after 
metabolic surgery) is also carcinogenic, especially regarding 
neuroendocrine tumors, gastrointestinal tumors, and prostate 
cancer.
Metabolic surgery is increasingly performed worldwide due 
to the advances of the obesity epidemic. Due to its profound 
metabolic effects, these procedures are no longer considered 
mere interventions for weight loss, and are increasingly 
applied in patients with lower body mass indexes. These 
procedures show a significant reduction in mortality and 
incidence of cancer. The protective role of metabolic surgery 
is stronger for tumors related to female obesity, although the 
anticancer activity of surgery may include weight-dependent 
or not effects. These include improvement of insulin resistance 
with attenuation of metabolic syndrome, as well as decreased 
oxidative stress and inflammation, the beneficial modulation 
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of sex steroids, intestine hormones, interleukins decrease and 
modulation of the immune system. Elucidating the precise 
mechanism of the metabolic surgery in cancer prevention 
can increase our understanding of how obesity, diabetes and 
metabolic syndrome are associated to oncogenesis.
This will require controlled and randomized in vitro and 
in vivo (animal models) carcinogenesis studies and metabolic 
surgery, which can result in the refinement of metabolic 
operations to maximize their anticancer effects. This can also 
offer new treatment approaches for tumors.
Bariatric surgery started with the sole aim of decreasing 
the weight of morbidly obese patients, but it has accidently 
widened the unexpected or initially planned benefits from 
surgery. In addition to the already established changes in 
quality of life and reduction of comorbidities, such as diabetes 
and hypertension, now rates of cancer in patients who 
underwent bariatric and metabolic surgery have decreased 
compared with non-operated obese patients.
Thi s opens a wide field of medical research, and certainly 
the benefits of this treatment will bring new and good surprises 
in the future!
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